Trial Profile
A placebo-controlled, double-blind study of Feldetrex, compared with FDA-approved regimens, in patients with neuropathic pain and fibromyalgia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2014
Price :
$35
*
At a glance
- Drugs Feldetrex (Primary)
- Indications Fibromyalgia; Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- 05 Aug 2014 New trial record